LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts LVTX Hot Sheet
Join SI Premium – FREE
LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Electra Therapeutics files for proposed IPO
- BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
